Opthea to Present at Clinical Trials at the Summit Meeting
Filed with ASX · · 3 pages · English
Earlier from Opthea
- Opthea Completes Enrollment in Phase 3 Clinical Program
- Opthea Corporate Presentation - April 2024
- Opthea Key Opinion Leader Even on Sozinibercept
- Opthea Corporate Presentation - March 2024
- Half Yearly Report and Accounts
Later from Opthea
- Trading Halt - Accelerated Offer
- Opthea Annouces Equity Raise
- Opthea Equity Raise Investor Presentation
- Opthea - Prospectus 2024
- Opthea Completes Placement & Institutional Entitlement Offer
Follow Opthea into a list and get an email when it puts out news.
Follow Opthea